{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21010 MSE Scabies Policy 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "SCABIES POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21010"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "01 March 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "28 February 2024"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Public Health Guidance"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling, Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Infection Prevention and Control Committees Basildon Hospital Broomfield Hospital Southend Hospital"
                    },
                    {
                        "text": "05 January 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience, Director of Harm Free Care"
                    },
                    {
                        "text": "05 January 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "23 February 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "March 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21010 MSE Scabies Policy 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Judith Holdsworth"
                    },
                    {
                        "text": "Lead ICN Broomfield"
                    },
                    {
                        "text": "31 December 2020"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist MSE"
                    },
                    {
                        "text": "31 December 2020"
                    },
                    {
                        "text": "Dr Awad-El -Kariem"
                    },
                    {
                        "text": "Consultant Microbiologist /DIPC Basildon"
                    },
                    {
                        "text": "05 February 2021"
                    },
                    {
                        "text": "Edith Mahachi"
                    },
                    {
                        "text": "Lead ICN Basildon"
                    },
                    {
                        "text": "05 February 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Southend IPCC"
                    },
                    {
                        "text": "05 February 2021"
                    },
                    {
                        "text": "Broomfield IPCC"
                    },
                    {
                        "text": "05 February 2021"
                    },
                    {
                        "text": "Basildon IPCC"
                    },
                    {
                        "text": "05 February 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Decontamination Policy Isolation Policy Hand Decontamination Policy Standard Precautions Linen Handling Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Newly created MSE document. Policy supersedes Southend IC044 Scabies Policy"
                    },
                    {
                        "text": "01 March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 4"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Management of Scabies ............................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Transmission ................................................................................................................ 7"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Diagnosis ...................................................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Specific Treatment for Scabies Infection ...................................................................... 8"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Control of Increased Incidences and Outbreaks ........................................................... 9  Training Requirements ................................................................................................. 9  Monitoring and Audit ..................................................................................................... 9  Approval and Implementation ..................................................................................... 10  Equality Impact Assessment ....................................................................................... 10  References ................................................................................................................. 10 Appendix 1: Preliminary Equality Analysis ......................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The provision of healthcare carries with it inherent risks to the health care worker. The purpose of this policy is to ensure that all staff are aware of their responsibilities for safe practice in relation to the management of scabies and take the appropriate precautionary measures to protect themselves, their co-workers and their patients. etc."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The  purpose  of  this  policy  is  to  provide  healthcare  workers  with  appropriate information  on  the identification,  management  and  prevention of  transmission  of scabies"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "type": "table",
            "sequence_num": 23,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Communicable Disease"
                    },
                    {
                        "text": "An infection which is capable of spreading from person to person"
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director of Infection Prevention and Control"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "PPE"
                    },
                    {
                        "text": "Personal Protective Equipment e.g. disposable gloves/ aprons"
                    },
                    {
                        "text": "Terminal Clean"
                    },
                    {
                        "text": "A full room clean performed by the Cleaning Response Team."
                    },
                    {
                        "text": "Outbreak"
                    },
                    {
                        "text": "The occurrence of two or more cases of the same infection linked in time and place or, the situation when the observed number of cases exceeds the number expected."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Duties of Individuals within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.1 Chief Executive The Chief Executive has overall responsibility for the strategic and operational management of the Trust"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.2 The Director of Infection Prevention and Control (DIPC)"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The DIPC oversees development and implementation of infection prevention and control policies in accordance with the Infection Prevention and Control Strategy."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.3 Infection Prevention and Control Team (IPCT) Responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the guidelines comply with all legal, statutory and good practice guidance requirements;"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing clinical leadership with this guideline implementation;"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Supporting the operational implementation of this guideline by providing advice and training;"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Improve and spreading best practice;"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Review the guideline in light of the outcomes from the periodic audits and to monitor its effectiveness during routine activities."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.4 Matrons / Ward Managers:"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Must be aware of the signs and symptoms of Scabies and be familiar with the policy"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promote good practice and challenge poor practice"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.5 Medical Staff:"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure compliance with scabies policies"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Follow advice from the Infection Prevention and Control Team relating to isolation of patients"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Review the need for isolation on a daily basis"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.6 All Healthcare staff"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Must adhere to scabies policy to reduce the risk of cross infection to patients and staff"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promote good practice and challenge poor practice"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Refer to the Infection Prevention Team if unable to follow the policy guidelines"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Keep patient informed of their infection status and provide information as necessary"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Must ensure that patients who are isolated with scabies are kept informed about their condition"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Management of Scabies"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Scabies is an infestation caused by a mite known as Sarcoptes scabiei, which burrows into the skin and lays its eggs. An allergy to mite eggs and the faecal droppings produced is responsible for symptoms of intense itching and a characteristic rash."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Scabies is known to cause sporadic cases and outbreaks in hospitals, nursing/residential homes, schools and any other communal care environments where people have direct prolonged skin contact. Effective control is dependent on early diagnosis, adequate treatment of cases and contacts and the prevention of further spread."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "The appearance and severity of symptoms are strongly influenced by the immune status of the affected person. Scabies may present as follows:"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.3.1 Classical Scabies"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This is the form of scabies generally found in healthy people with a normal immune system"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The number of mites present in classical scabies is small (15-20) and spread is usually by direct physical contact"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Burrows appear as irregular, raised discoloured lines 0.5 to 1.5cm long in the skin, which are not always visible to the naked eye."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Often a bilateral symmetrical rash can be seen in areas such as the midriff, inner thighs and axillae"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is extreme itching, especially at night"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The sites of the rash and burrows do not necessarily correspond"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "type": "image",
            "sequence_num": 59,
            "data": {
                "url": "MSEPO-21010 MSE Scabies Policy 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.3.2 Crusted Scabies (Norwegian Scabies)"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This form of scabies is extremely infectious and occurs in those whose immune systems are severely impaired"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Hyperkeratotic skin lesions appear as hardened crusts containing thousands or millions of mites"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Itching may be slight or absent"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Skin becomes crusted especially on palms, soles, nail beds, wrists, buttocks and penis"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The whole body can be affected including the head and scalp"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "type": "image",
            "sequence_num": 66,
            "data": {
                "url": "MSEPO-21010 MSE Scabies Policy 1.0.005.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Transmission"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 48.0,
                "text": "Scabies is mainly spread from person to person by direct, prolonged skin contact with an infected person, such as prolonged holding of hands. Scabies mites rapidly die, once away from the human body and therefore clothing and linen etc. is not the main route for transmission. However, mites shed in skin scales, can live in the environment longer and therefore the risk of spread through contact with soft furnishings / carpets clothing and linen is increased with heavy skin shedders. The length of time between contact with an affected person and developing signs of scabies (i.e. itching and a rash) is between four and six weeks, if this is the first infection. For re-infection symptoms appear within  hours."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Diagnosis"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Diagnosis is by identification of the mite, eggs or faecal matter from skin scrapings. A clinical diagnosis may be made by a combination of severe itching especially at night and a typical or atypical distribution of a rash in persons who have had skin to skin contact with suspected or diagnosed cases. If clinical diagnosis is difficult, obtaining skin scrapings for the scabies mites or their faecal pellets may be helpful. Skin scales may be sent by the clinician caring for the patient in a closed, sealed container (e.g. universal container) to the lab for microscopy for scabies. Once the diagnosis is confirmed a dermatology opinion may be necessary."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Infection Control Precautions"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.1 All patients in communal health care environments who are suspected of having or have been diagnosed as having scabies should be cared for in source isolation until treatment has been administered and washed off, or an alternative diagnosis has been made. The infection prevention and control team must be informed of the patient as soon as possible. Two courses of treatment are required and must be administered at least one week apart."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.2 Precautions must continue until the two courses of treatment have been administered and washed off or an alternative diagnosis made."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.3 Disposable nitrile gloves and sleeved plastic aprons are to be worn when in contact with the patient, bed linen and patients clothing. The use of personal protective equipment (PPE) should be used until the second course of treatment has been administered and washed off."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.4 Hand washing with liquid soap and water should be carried out after contact with the patient and their environment. Hands must be dried thoroughly with single use disposable paper towels."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.5 Hand washing with liquid soap and water should be carried out after removing gloves and aprons. Hands must be dried thoroughly with single use disposable paper towels."
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.6 Linen should be treated as infected until the patient has had the second course of treatment. Clean clothing and bed linen should be available after treatment has been washed off."
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Specific Treatment for Scabies Infection"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "Individual Treatment Individual treatment should be given if scabies is diagnosed."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Recommended Treatments"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Adults & Children aged 2months & over (including pregnant & breast feeding women)"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Permethrin 5% (Lyclear Dermal Cream\u00ae 30g) low toxicity, non-irritant"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Once weekly x 2 doses"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Leave for 8-12 hours, and wash off."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Adults & Children aged 6months & over"
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Malathion 0.5% (Derbac-M\u00ae liquid 200ml) contains alcohol"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Once weekly x 2doses"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Leave for 24hours, and wash off"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Alcohol lotions are not recommended in children with severe eczema or asthma (Only use in pregnant & breast feeding women if permethrin is not appropriate)"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Children Under 2months Permethrin 5% is unlicensed in infants under 2months, but may be used under medical supervision."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Alternative: Crotamiton 10% (Eurax\u00ae cream/lotion) 50-70% efficacy"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Crotamiton is very soothing. It eases itching, softens skin and it kills scabies mites."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Apply daily for 3 to 5 days."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Leave for 24hours after each application, and wash off thoroughly. Reapply the cream each day"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.3,
                "text": "Treatment Dose"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Volume of application depends on the size of the patient. A large person will need 2 or more treatment packs."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.4,
                "text": "Application of Treatment"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The lotion or cream should be applied to all skin surfaces including the scalp, neck, face and ears. Special attention should be paid to the areas between the fingers, toes, under the nails, behind the ears and extending to the soles of the feet. It should be applied to cool dry skin and never after a hot bath. Avoid contacts with the eyes."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The lotion or cream should be re-applied to any part of the skin that has been washed during the treatment time (e.g the hands), as these areas will not undergo the recommended time for treatment, and may promote reinfection."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Following the recommended time, depending on the type of medication used, the lotion or cream should be washed off thoroughly with plenty of water. This should be done preferably by a shower (or bath if a shower is not an option)"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Treatment with Malathion or Permethrin should be repeated after one week."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Itching may persist and the rash may be present for up to 2 weeks after treatment and elimination of infestation. The use of calamine lotion, crotamiton or antihistamines may be helpful in the management of itching. However, persistent symptoms may suggest that scabies eradication was not successful."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Nightclothes and bedding used in the 48 hours prior to and during the treatment should be placed into a pink soluble bag and securely tied before being placed into"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "text": "a white outer plastic bag"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All members of the affected household should be advised to undergo treatment."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Control of Increased Incidences and Outbreaks"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If two or more cases of scabies are detected on the same ward and are linked in time (2 weeks or less apart), then the Infection Prevention and Control Team must be notified"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If an increased incident or outbreak is suspected, referral to a dermatologist is required to urgently confirm diagnosis of scabies. The referral for patients should be made by their clinician .Staff should have confirmation from their GP."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Once an increased incident/outbreak has been identified the increased incident/outbreak policy will be implemented"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Planned coordinated treatment is essential and where possible, individuals should be treated at the same time to prevent the likelihood of re-infection"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the exceptional case of an Outbreak, where to facilitate Infection Control of scabies then, if authorised with appropriate direction from Public Health then Occupational Health can prescribe appropriate medication which are not designated prescription only medication to be issued via the hospital pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All Trust staff to undertake Mandatory Infection Prevention and Control up dates. The IPCT has primary responsibility for providing training on the policy where needed. Managers have the responsibly to support the IPCT by ensuring that staff are able to attend training sessions in response to identified needs."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "type": "table",
            "sequence_num": 116,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Knowledge and practice in relation to this specific policy"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "On a case by case basis"
                    },
                    {
                        "text": "Site IPCC"
                    },
                    {
                        "text": "MSE IPCC"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "All policies, procedures and guidelines will be approved by the sites IPCC'S, which are the specialist groups with the authority to approve local policies/guidelines. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "It is the author's responsibility to inform the Director of Harm Free Care  of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "British Association of Dermatologist: http://www.bad.org.uk/ResourceListing.aspx?sitesectionid=159&itemid=377"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "CDC: http://www.cdc.gov/parasites/scabies/"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Scabies Policy / MSEPO-21010 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Scabies Policy / MSEPO-21010 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Scabies Policy MSEPO-21010: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "type": "table",
            "sequence_num": 130,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 131,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "To amend a single policy to cover the MSE"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To have a single MSE policy"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "All staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes, refer to pages 1 & 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 132,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head Nurse Infection Control MSE"
                    },
                    {
                        "text": "28 February 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 134
        }
    ]
}